The Comparison of Mutational Progression in SARS-CoV-2: A Short Updated Overview

The Comparison of Mutational Progression in SARS-CoV-2: A Short Updated Overview

The COVID-19 pandemic has impacted the world population adversely, posing a threat to human health. In the past few years, various strains of SARS-CoV-2, each with different mutations in its structure, have impacted human health in negative ways. The severe acute respiratory syndrome coronavirus 2 (...

Full description

Bibliographic Details
Main Authors:	Abeer Asif, Iqra Ilyas, Mohammad Abdullah, Sadaf Sarfraz, Muhammad Mustafa, Arif Mahmood
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Journal of Molecular Pathology
Subjects:	COVID-19 SARS-CoV-2 mutations S1 domain S2 domain comparison of SARS-CoV-2 strains
Online Access:	https://www.mdpi.com/2673-5261/3/4/18

Similar Items

Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
by: Yang Yang, et al.
Published: (2024-05-01)

Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants
by: Alice Massacci, et al.
Published: (2020-12-01)

The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV
by: Mayanka Awasthi, et al.
Published: (2020-08-01)

On the SARS-CoV-2 Variants
by: Fabio Scarpa, et al.
Published: (2024-03-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

A high-throughput response to the SARS-CoV-2 pandemic
by: Lynn Rasmussen, et al.
Published: (2024-07-01)

Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA
by: Neha Kaushal, et al.
Published: (2020-07-01)

A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV
by: Xiaoqing Guan, et al.
Published: (2024-06-01)

Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor
by: Arun Bahadur Gurung, et al.
Published: (2022-02-01)

Structural and Phylogenetic Analysis of SARS-CoV-2 Spike Glycoprotein from the Most Widespread Variants
by: Emilia Caputo, et al.
Published: (2022-08-01)

Combining MOE Bioinformatics Analysis and In Vitro Pseudovirus Neutralization Assays to Predict the Neutralizing Ability of CV30 Monoclonal Antibody on SARS-CoV-2 Variants
by: Yajuan Zhu, et al.
Published: (2023-07-01)

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

Optimizing the Illumina COVIDSeq laboratorial and bioinformatics pipeline on thousands of samples for SARS-CoV-2 Variants of Concern tracking
by: Sara Donzelli, et al.
Published: (2022-01-01)

An Overview of the Pathogenesis, Transmission, Diagnosis, and Management of Endemic Human Coronaviruses: A Reflection on the Past and Present Episodes and Possible Future Outbreaks
by: Adeoye J. Kayode, et al.
Published: (2021-08-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

SARS-CoV-2: Searching for the Missing Variants
by: Emilia Caputo, et al.
Published: (2022-10-01)

Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL)
by: Natalia Ruetalo, et al.
Published: (2021-11-01)

Fixation and reversion of mutations in the receptor-binding domain of the SARS-CoV-2 spike protein: A 2020–2024 analysis
by: Daniele Focosi, et al.
Published: (2024-12-01)

Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2
by: Juan Shi, et al.
Published: (2023-03-01)

Most accurate mutations in SARS-CoV-2 genomes identified in Uzbek patients show novel amino acid changes
by: Mirzakamol S. Ayubov, et al.
Published: (2024-05-01)

Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach
by: Taimoor Khan, et al.
Published: (2022-04-01)

Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents
by: Naomi S. Coombes, et al.
Published: (2023-02-01)

SARS-CoV-2 and other Coronaviruses: A matter of variations
by: Ibtesam Ghadban Auda, et al.
Published: (2023-04-01)

An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
by: Varghese Edwin Hillary, et al.
Published: (2023-03-01)

Emerging Mutations in Nsp1 of SARS-CoV-2 and Their Effect on the Structural Stability
by: Kejie Mou, et al.
Published: (2021-10-01)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
by: Ashutosh Khaswal, et al.
Published: (2022-07-01)

Comparison of Immunological Profiles of SARS-CoV-2 Variants in the COVID-19 Pandemic Trends: An Immunoinformatics Approach
by: Jenifer Mallavarpu Ambrose, et al.
Published: (2021-05-01)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
by: Hatem A. Elshabrawy
Published: (2020-06-01)

Interspecies transmission of SARS CoV-2 with special emphasis on viral mutations and ACE-2 receptor homology roles
by: Mervat E. Hamdy, et al.
Published: (2023-12-01)

Detecting Potentially Adaptive Mutations from the Parallel and Fixed Patterns in SARS-CoV-2 Evolution
by: Cheng-Yang Ji, et al.
Published: (2022-05-01)

Spatio-Temporal Mutational Profile Appearances of Swedish SARS-CoV-2 during the Early Pandemic
by: Jiaxin Ling, et al.
Published: (2020-09-01)

“Mutation blacklist” and “mutation whitelist” of SARS-CoV-2
by: Yamin Sun, et al.
Published: (2022-12-01)

Comparative transcriptome analysis of SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-229E identifying potential IFN/ISGs targets for inhibiting virus replication
by: Yuzhuang Liu, et al.
Published: (2023-12-01)

Unlocking the puzzle: non-defining mutations in SARS-CoV-2 proteome may affect vaccine effectiveness
by: Eugenia Ulzurrun, et al.
Published: (2024-08-01)

Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples
by: Andrea Aroldi, et al.
Published: (2022-12-01)

Emerging mutation in SARS-CoV-2 spike: Widening distribution over time in different geographic areas
by: Ysrafil Ysrafil, et al.
Published: (2021-10-01)

Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
by: Takanari Hattori, et al.
Published: (2022-08-01)

SARS-COV-2: INSIGHT INTO THE EMERGING GENETIC VARIANTS
by: Neli Korsun, et al.
Published: (2022-02-01)

Comment on Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. <i>Pharmaceutics</i> 2021, <i>13</i>, 502
by: Milad Zandi, et al.
Published: (2022-09-01)

Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients
by: Bertram Flehmig, et al.
Published: (2020-11-01)